Silybum

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 5175 Experts worldwide ranked by ideXlab platform

Richard J. Martin - One of the best experts on this subject based on the ideXlab platform.

T Kephalas - One of the best experts on this subject based on the ideXlab platform.

Ercan Bursal - One of the best experts on this subject based on the ideXlab platform.

  • in vitro antioxidant activity of silymarin
    Journal of Enzyme Inhibition and Medicinal Chemistry, 2009
    Co-Authors: Ekrem Koksal, Ilhami Gulcin, Sevim Beyza, Ozturk Sarikaya, Ercan Bursal
    Abstract:

    Silymarin, a known standardized extract obtained from seeds of Silybum marianum is widely used in treatment of several diseases of varying origin. In the present paper, we clarified the antioxidant...

Veronika Butterweck - One of the best experts on this subject based on the ideXlab platform.

  • in vitro inhibitory potential of cynara scolymus Silybum marianum taraxacum officinale and peumus boldus on key enzymes relevant to metabolic syndrome
    Phytomedicine, 2015
    Co-Authors: Angela Villiger, Filippo Sala, Andy Suter, Veronika Butterweck
    Abstract:

    Boldocynara®, a proprietary dietary supplement product consisting of the plants Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus, used to promote functions of the liver and the gallbladder. It was the aim of the present study to look from a different perspective at the product by investigating the in vitro potential of Boldocynara® as a combination product and its individual extracts on key enzymes relevant to metabolic syndrome. Peumus boldus extract exhibited pronounced inhibitory activities on α-glucosidase (80% inhibition at 100 µg/ml, IC50: 17.56 µg/ml). Silybum marianum had moderate pancreatic lipase (PL) inhibitory activities (30% at 100 µg/ml) whereas Cynara scolymus showed moderate ACE inhibitory activity (31% at 100 µg/ml). The combination had moderate to weak effects on the tested enzymes. In conclusion, our results indicate some moderate potential of the dietary supplement Boldocynara® and its single ingredients for the prevention of metabolic disorders.

Wendy A. Smith - One of the best experts on this subject based on the ideXlab platform.